Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs PPL Corporation Common Stock (PPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs PPL Corporation Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while PPL Corporation Common Stock trades at $34.19 (market cap $25.66B). The key difference: PPL Corporation Common Stock is far larger — about 2× Halozyme Therapeutics Inc. Common Stock's market cap, and PPL Corporation Common Stock pays a 3.34% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and PPL Corporation Common Stock for 0 Days on average.
| HALO | PPL | |
|---|---|---|
Market Cap | $12.58B | $25.66B |
Volume | 2,179,278 | 9,090,489 |
Sector | Health | Utilities |
52-Week High | $115.22 | $39.81 |
52-Week Low | $61.63 | $31.97 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $14.49B | $45.65B |
Dividend Yield | — | 3.34% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About PPL Corporation Common Stock
PPL Corporation is a regulated utility holding company. Through its subsidiaries, it generates, transmits, distributes, and sells electricity and natural gas in Kentucky, Pennsylvania, and Rhode Island.
Read more on PPL →
